ML Lab deal

MLB's Innovata Biomed respiratory division granted an undisclosed pharma company exclusive rights to market and distribute a combination of two marketed respiratory drugs in Innovata's C200 dry powder inhaler. The pharma company's rights include Europe and certain other countries, and Innovata retains rights elsewhere, including the U.S. and Japan. ...